HIV-2 mediated effects on target and bystander cells induce plasma proteome remodeling
- PMID: 38500818
- PMCID: PMC10945182
- DOI: 10.1016/j.isci.2024.109344
HIV-2 mediated effects on target and bystander cells induce plasma proteome remodeling
Abstract
Despite low or undetectable plasma viral load, people living with HIV-2 (PLWH2) typically progress toward AIDS. The driving forces behind HIV-2 disease progression and the role of viremia are still not known, but low-level replication in tissues is believed to play a role. To investigate the impact of viremic and aviremic HIV-2 infection on target and bystander cell pathology, we used data-independent acquisition mass spectrometry to determine plasma signatures of tissue and cell type engagement. Proteins derived from target and bystander cells in multiple tissues, such as the gastrointestinal tract and brain, were detected at elevated levels in plasma of PLWH2, compared with HIV negative controls. Moreover, viremic HIV-2 infection appeared to induce enhanced release of proteins from a broader range of tissues compared to aviremic HIV-2 infection. This study expands the knowledge on the link between plasma proteome remodeling and the pathological cell engagement in tissues during HIV-2 infection.
Keywords: Disease; Human specimen; Proteomics; Virology.
© 2024 The Authors.
Conflict of interest statement
The authors or their institutions declare no competing financial interests and did not at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for any aspect of the submitted work (including data monitoring board, study design, manuscript preparation, statistical analysis, etc.). The authors have no patents, whether planned, pending, or issued, broadly relevant to the work.
Figures





Similar articles
-
Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings.AIDS Res Ther. 2020 Jul 16;17(1):43. doi: 10.1186/s12981-020-00298-9. AIDS Res Ther. 2020. PMID: 32678033 Free PMC article.
-
Inverted CD8 T-Cell Exhaustion and Co-Stimulation Marker Balance Differentiate Aviremic HIV-2-Infected From Seronegative Individuals.Front Immunol. 2021 Oct 12;12:744530. doi: 10.3389/fimmu.2021.744530. eCollection 2021. Front Immunol. 2021. PMID: 34712231 Free PMC article.
-
Molecular biological assessment methods and understanding the course of the HIV infection.APMIS Suppl. 2003;(114):1-37. APMIS Suppl. 2003. PMID: 14626050 Review.
-
Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.J Virol. 2022 Jan 26;96(2):e0153521. doi: 10.1128/JVI.01535-21. Epub 2021 Nov 10. J Virol. 2022. PMID: 34757843 Free PMC article.
-
Host and Viral Factors in HIV-Mediated Bystander Apoptosis.Viruses. 2017 Aug 22;9(8):237. doi: 10.3390/v9080237. Viruses. 2017. PMID: 28829402 Free PMC article. Review.
References
-
- Esbjörnsson J., Månsson F., Kvist A., da Silva Z.J., Andersson S., Fenyö E.M., Isberg P.E., Biague A.J., Lindman J., Palm A.A., et al. Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study. Lancet. HIV. 2018;6:e25–e31. doi: 10.1016/S2352-3018(18)30254-6. - DOI - PubMed
-
- de Silva T.I., Aasa-Chapman M., Cotten M., Hué S., Robinson J., Bibollet-Ruche F., Sarge-Njie R., Berry N., Jaye A., Aaby P., et al. Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes. J. Virol. 2012;86:930–946. doi: 10.1128/JVI.06126-11. - DOI - PMC - PubMed
-
- Duvall M.G., Jaye A., Dong T., Brenchley J.M., Alabi A.S., Jeffries D.J., van der Sande M., Togun T.O., McConkey S.J., Douek D.C., et al. Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection. J. Immunol. 2006;176:6973–6981. doi: 10.4049/jimmunol.176.11.6973. - DOI - PubMed
LinkOut - more resources
Full Text Sources